Westchester Capital Management (New York)’s Envoy Medical COCH Stock Holding History

Westchester Capital Management (New York)’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-108,000	Closed	-$1.13M	–	275
2023 Q3	$1.13M	Buy	+108,000	New	+$1.08M	0.03%	206
2023 Q1	–	Sell	-656,307	Closed	-$6.63M	–	364
2022 Q4	$6.63M	Buy	656,307 +200,000	+44%	+$1.99M	0.18%	131
2022 Q3	$4.49M	Hold	456,307	–	–	0.13%	180
2022 Q2	$4.47M	Hold	456,307	–	–	0.12%	167
2022 Q1	$4.46M	Hold	456,307	–	–	0.12%	168
2021 Q4	$4.45M	Buy	+456,307	New	+$4.45M	0.13%	140

Other funds holding COCH

AMC

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.67% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.82% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Westchester Capital Management (New York)'s COCH Position: Q4 2023 in Review

Westchester Capital Management (New York) sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 108,000 shares — an estimated $1.13M sold.

Westchester Capital Management (New York) first reported a position in COCH in Q4 2021 and held it in 6 quarters. The position peaked at $6.63M in Q4 2022. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

Westchester Capital Management (New York) reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 108,000 Envoy Medical shares in Q4 2023, an estimated $1.13M.
Westchester Capital Management (New York) first reported a position in Envoy Medical in Q4 2021 and held it in 6 quarters.
Westchester Capital Management (New York)'s Envoy Medical position peaked at $6.63M in Q4 2022.
9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2023, filed 15 Feb 2024.